Science 37 Logo.jpg
Science 37 Reports Second Quarter 2022 Financial Results
11 août 2022 06h00 HE | Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial...
Science 37 Logo.jpg
Science 37 to Report Second Quarter 2022 Financial Results on August 11, 2022
28 juil. 2022 07h55 HE | Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 28, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report second quarter...
Science 37 Logo.jpg
Oncology Clinical Trial Execs to Increase Decentralization, Science 37 Survey Indicates
15 juin 2022 07h55 HE | Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., June 15, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today published new data from oncology clinical...
Science 37 Logo.jpg
Science 37® to Participate in Upcoming Investor Conferences
07 juin 2022 07h55 HE | Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., June 07, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating...
Science 37 Logo.jpg
Science 37® to Present at the William Blair 42nd Annual Growth Stock Conference
25 mai 2022 07h55 HE | Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 25, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating...
Science 37 Logo.jpg
Science 37 Introduces Virtual Site Model to Rescue Slow Enrolling Clinical Trials
12 mai 2022 16h01 HE | Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 12, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today introduced a rapid-deployment virtual site...
Science 37 Logo.jpg
Science 37® Extends Leadership in Decentralized Clinical Trial Market with NextGen SaaS Release to Fully Orchestrate Decentralized Study Conduct
10 mai 2022 07h55 HE | Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today introduced a milestone technology release,...
Science 37 Logo.jpg
Science 37 Reports First Quarter 2022 Financial Results
09 mai 2022 06h00 HE | Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., May 09, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial...
Science 37 Logo.jpg
Science 37 to Report First Quarter 2022 Financial Results on May 9, 2022
25 avr. 2022 07h55 HE | Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., April 25, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report first quarter...
Science 37 Logo.jpg
Science 37® Adds Acclaimed Researcher and Oncologist, Dr. Shaalan Beg to Bolster Therapeutic Depth
31 mars 2022 07h55 HE | Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., March 31, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it is fortifying its oncology...